Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.
Identifieur interne : 002330 ( PubMed/Curation ); précédent : 002329; suivant : 002331Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.
Auteurs : Henry Chrystyn [Royaume-Uni] ; David B. Price [Royaume-Uni] ; Mathieu Molimard [France] ; John Haughney [Royaume-Uni] ; Sinthia Bosnic-Anticevich [Australie] ; Federico Lavorini [Italie] ; John Efthimiou [Royaume-Uni] ; Dawn Shan [Royaume-Uni] ; Erika Sims [Royaume-Uni] ; Anne Burden [Royaume-Uni] ; Catherine Hutton [Royaume-Uni] ; Nicolas Roche [France]Source :
- BMC pulmonary medicine [ 1471-2466 ] ; 2016.
Descripteurs français
- KwdFr :
- Administration par inhalation, Adulte, Adulte d'âge moyen, Agonistes bêta-adrénergiques (administration et posologie), Asthme (traitement médicamenteux), Broncho-pneumopathie chronique obstructive (traitement médicamenteux), Conception d'appareillage, Femelle, Hormones corticosurrénaliennes (administration et posologie), Humains, Inhalateurs à poudre sèche, Mâle, Odds ratio, Sujet âgé, Études croisées.
- MESH :
- administration et posologie : Agonistes bêta-adrénergiques, Hormones corticosurrénaliennes.
- traitement médicamenteux : Asthme, Broncho-pneumopathie chronique obstructive.
- Administration par inhalation, Adulte, Adulte d'âge moyen, Conception d'appareillage, Femelle, Humains, Inhalateurs à poudre sèche, Mâle, Odds ratio, Sujet âgé, Études croisées.
English descriptors
- KwdEn :
- Administration, Inhalation, Adrenal Cortex Hormones (administration & dosage), Adrenergic beta-Agonists (administration & dosage), Adult, Aged, Asthma (drug therapy), Cross-Over Studies, Dry Powder Inhalers, Equipment Design, Female, Humans, Male, Middle Aged, Odds Ratio, Pulmonary Disease, Chronic Obstructive (drug therapy).
- MESH :
- chemical , administration & dosage : Adrenal Cortex Hormones, Adrenergic beta-Agonists.
- drug therapy : Asthma, Pulmonary Disease, Chronic Obstructive.
- Administration, Inhalation, Adult, Aged, Cross-Over Studies, Dry Powder Inhalers, Equipment Design, Female, Humans, Male, Middle Aged, Odds Ratio.
Abstract
Serious inhaler technique errors can impair drug delivery to the lungs. This randomised, crossover, open-label study evaluated the proportion of patients making predefined serious errors with Pulmojet compared with Diskus and Turbohaler dry powder inhalers.
DOI: 10.1186/s12890-016-0169-5
PubMed: 26769482
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002362
Links to Exploration step
pubmed:26769482Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.</title>
<author><name sortKey="Chrystyn, Henry" sort="Chrystyn, Henry" uniqKey="Chrystyn H" first="Henry" last="Chrystyn">Henry Chrystyn</name>
<affiliation wicri:level="1"><nlm:affiliation>Inhalation Consultancy Ltd, Yeadon, Leeds, West Yorkshire, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Inhalation Consultancy Ltd, Yeadon, Leeds, West Yorkshire</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Price, David B" sort="Price, David B" uniqKey="Price D" first="David B" last="Price">David B. Price</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK. dprice@rirl.org.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Molimard, Mathieu" sort="Molimard, Mathieu" uniqKey="Molimard M" first="Mathieu" last="Molimard">Mathieu Molimard</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Pharmacology, CHU et Univ. de Bordeaux, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Medical Pharmacology, CHU et Univ. de Bordeaux, Bordeaux</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Haughney, John" sort="Haughney, John" uniqKey="Haughney J" first="John" last="Haughney">John Haughney</name>
<affiliation wicri:level="1"><nlm:affiliation>Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bosnic Anticevich, Sinthia" sort="Bosnic Anticevich, Sinthia" uniqKey="Bosnic Anticevich S" first="Sinthia" last="Bosnic-Anticevich">Sinthia Bosnic-Anticevich</name>
<affiliation wicri:level="1"><nlm:affiliation>Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney and Sydney Local Health District, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney and Sydney Local Health District, Sydney</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lavorini, Federico" sort="Lavorini, Federico" uniqKey="Lavorini F" first="Federico" last="Lavorini">Federico Lavorini</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Efthimiou, John" sort="Efthimiou, John" uniqKey="Efthimiou J" first="John" last="Efthimiou">John Efthimiou</name>
<affiliation wicri:level="1"><nlm:affiliation>Horizon Respiratory Consultancy, Oxford, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Horizon Respiratory Consultancy, Oxford</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shan, Dawn" sort="Shan, Dawn" uniqKey="Shan D" first="Dawn" last="Shan">Dawn Shan</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sims, Erika" sort="Sims, Erika" uniqKey="Sims E" first="Erika" last="Sims">Erika Sims</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Burden, Anne" sort="Burden, Anne" uniqKey="Burden A" first="Anne" last="Burden">Anne Burden</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hutton, Catherine" sort="Hutton, Catherine" uniqKey="Hutton C" first="Catherine" last="Hutton">Catherine Hutton</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Roche, Nicolas" sort="Roche, Nicolas" uniqKey="Roche N" first="Nicolas" last="Roche">Nicolas Roche</name>
<affiliation wicri:level="1"><nlm:affiliation>University Paris Descartes (EA2511), Respiratory and Intensive Care Medicine Department, Cochin Hospital Group, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Paris Descartes (EA2511), Respiratory and Intensive Care Medicine Department, Cochin Hospital Group, AP-HP, Paris</wicri:regionArea>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2016">2016</date>
<idno type="RBID">pubmed:26769482</idno>
<idno type="pmid">26769482</idno>
<idno type="doi">10.1186/s12890-016-0169-5</idno>
<idno type="wicri:Area/PubMed/Corpus">002362</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002362</idno>
<idno type="wicri:Area/PubMed/Curation">002330</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002330</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.</title>
<author><name sortKey="Chrystyn, Henry" sort="Chrystyn, Henry" uniqKey="Chrystyn H" first="Henry" last="Chrystyn">Henry Chrystyn</name>
<affiliation wicri:level="1"><nlm:affiliation>Inhalation Consultancy Ltd, Yeadon, Leeds, West Yorkshire, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Inhalation Consultancy Ltd, Yeadon, Leeds, West Yorkshire</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Price, David B" sort="Price, David B" uniqKey="Price D" first="David B" last="Price">David B. Price</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK. dprice@rirl.org.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Molimard, Mathieu" sort="Molimard, Mathieu" uniqKey="Molimard M" first="Mathieu" last="Molimard">Mathieu Molimard</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Medical Pharmacology, CHU et Univ. de Bordeaux, Bordeaux, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Department of Medical Pharmacology, CHU et Univ. de Bordeaux, Bordeaux</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Haughney, John" sort="Haughney, John" uniqKey="Haughney J" first="John" last="Haughney">John Haughney</name>
<affiliation wicri:level="1"><nlm:affiliation>Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Bosnic Anticevich, Sinthia" sort="Bosnic Anticevich, Sinthia" uniqKey="Bosnic Anticevich S" first="Sinthia" last="Bosnic-Anticevich">Sinthia Bosnic-Anticevich</name>
<affiliation wicri:level="1"><nlm:affiliation>Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney and Sydney Local Health District, Sydney, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney and Sydney Local Health District, Sydney</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Lavorini, Federico" sort="Lavorini, Federico" uniqKey="Lavorini F" first="Federico" last="Lavorini">Federico Lavorini</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.</nlm:affiliation>
<country xml:lang="fr">Italie</country>
<wicri:regionArea>Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Efthimiou, John" sort="Efthimiou, John" uniqKey="Efthimiou J" first="John" last="Efthimiou">John Efthimiou</name>
<affiliation wicri:level="1"><nlm:affiliation>Horizon Respiratory Consultancy, Oxford, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Horizon Respiratory Consultancy, Oxford</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Shan, Dawn" sort="Shan, Dawn" uniqKey="Shan D" first="Dawn" last="Shan">Dawn Shan</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Sims, Erika" sort="Sims, Erika" uniqKey="Sims E" first="Erika" last="Sims">Erika Sims</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Burden, Anne" sort="Burden, Anne" uniqKey="Burden A" first="Anne" last="Burden">Anne Burden</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Hutton, Catherine" sort="Hutton, Catherine" uniqKey="Hutton C" first="Catherine" last="Hutton">Catherine Hutton</name>
<affiliation wicri:level="1"><nlm:affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</nlm:affiliation>
<country xml:lang="fr">Royaume-Uni</country>
<wicri:regionArea>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Roche, Nicolas" sort="Roche, Nicolas" uniqKey="Roche N" first="Nicolas" last="Roche">Nicolas Roche</name>
<affiliation wicri:level="1"><nlm:affiliation>University Paris Descartes (EA2511), Respiratory and Intensive Care Medicine Department, Cochin Hospital Group, AP-HP, Paris, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>University Paris Descartes (EA2511), Respiratory and Intensive Care Medicine Department, Cochin Hospital Group, AP-HP, Paris</wicri:regionArea>
</affiliation>
</author>
</analytic>
<series><title level="j">BMC pulmonary medicine</title>
<idno type="eISSN">1471-2466</idno>
<imprint><date when="2016" type="published">2016</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Administration, Inhalation</term>
<term>Adrenal Cortex Hormones (administration & dosage)</term>
<term>Adrenergic beta-Agonists (administration & dosage)</term>
<term>Adult</term>
<term>Aged</term>
<term>Asthma (drug therapy)</term>
<term>Cross-Over Studies</term>
<term>Dry Powder Inhalers</term>
<term>Equipment Design</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
<term>Pulmonary Disease, Chronic Obstructive (drug therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Administration par inhalation</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Agonistes bêta-adrénergiques (administration et posologie)</term>
<term>Asthme (traitement médicamenteux)</term>
<term>Broncho-pneumopathie chronique obstructive (traitement médicamenteux)</term>
<term>Conception d'appareillage</term>
<term>Femelle</term>
<term>Hormones corticosurrénaliennes (administration et posologie)</term>
<term>Humains</term>
<term>Inhalateurs à poudre sèche</term>
<term>Mâle</term>
<term>Odds ratio</term>
<term>Sujet âgé</term>
<term>Études croisées</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Adrenal Cortex Hormones</term>
<term>Adrenergic beta-Agonists</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Agonistes bêta-adrénergiques</term>
<term>Hormones corticosurrénaliennes</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Asthma</term>
<term>Pulmonary Disease, Chronic Obstructive</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Asthme</term>
<term>Broncho-pneumopathie chronique obstructive</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Administration, Inhalation</term>
<term>Adult</term>
<term>Aged</term>
<term>Cross-Over Studies</term>
<term>Dry Powder Inhalers</term>
<term>Equipment Design</term>
<term>Female</term>
<term>Humans</term>
<term>Male</term>
<term>Middle Aged</term>
<term>Odds Ratio</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Administration par inhalation</term>
<term>Adulte</term>
<term>Adulte d'âge moyen</term>
<term>Conception d'appareillage</term>
<term>Femelle</term>
<term>Humains</term>
<term>Inhalateurs à poudre sèche</term>
<term>Mâle</term>
<term>Odds ratio</term>
<term>Sujet âgé</term>
<term>Études croisées</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">Serious inhaler technique errors can impair drug delivery to the lungs. This randomised, crossover, open-label study evaluated the proportion of patients making predefined serious errors with Pulmojet compared with Diskus and Turbohaler dry powder inhalers.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">26769482</PMID>
<DateCreated><Year>2016</Year>
<Month>01</Month>
<Day>15</Day>
</DateCreated>
<DateCompleted><Year>2016</Year>
<Month>10</Month>
<Day>05</Day>
</DateCompleted>
<DateRevised><Year>2017</Year>
<Month>09</Month>
<Day>23</Day>
</DateRevised>
<Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2466</ISSN>
<JournalIssue CitedMedium="Internet"><Volume>16</Volume>
<PubDate><Year>2016</Year>
<Month>Jan</Month>
<Day>14</Day>
</PubDate>
</JournalIssue>
<Title>BMC pulmonary medicine</Title>
<ISOAbbreviation>BMC Pulm Med</ISOAbbreviation>
</Journal>
<ArticleTitle>Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study.</ArticleTitle>
<Pagination><MedlinePgn>12</MedlinePgn>
</Pagination>
<ELocationID EIdType="doi" ValidYN="Y">10.1186/s12890-016-0169-5</ELocationID>
<Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Serious inhaler technique errors can impair drug delivery to the lungs. This randomised, crossover, open-label study evaluated the proportion of patients making predefined serious errors with Pulmojet compared with Diskus and Turbohaler dry powder inhalers.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">Patients ≥18 years old with asthma and/or COPD who were current users of an inhaler but naïve to the study devices were assigned to inhaler technique assessment on Pulmojet and either Diskus or Turbohaler in a randomised order. Patients inhaled through empty devices after reading the patient information leaflet. If serious errors potentially affecting dose delivery were recorded, they repeated the inhalations after watching a training video. Inhaler technique was assessed by a trained nurse observer and an electronic inhalation profile recorder.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Baseline patient characteristics were similar between randomisation arms for the Pulmojet-Diskus (n = 277) and Pulmojet-Turbohaler (n = 144) comparisons. Non-inferiority in the proportions of patients recording no nurse-observed serious errors was demonstrated for both Pulmojet versus Diskus, and Pulmojet versus Turbohaler; therefore, superiority was tested. Patients were significantly less likely to make ≥1 nurse-observed serious errors using Pulmojet compared with Diskus (odds ratio, 0.31; 95 % CI, 0.19-0.51) or Pulmojet compared with Turbohaler (0.23; 0.12-0.44) after reading the patient information leaflet with additional video instruction, if required.</AbstractText>
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">These results suggest Pulmojet is easier to learn to use correctly than the Turbohaler or Diskus for current inhaler users switching to a new dry powder inhaler.</AbstractText>
<AbstractText Label="TRIAL REGISTRATION" NlmCategory="BACKGROUND">ClinicalTrials.gov Identifier: NCT01794390 (February 14, 2013).</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Chrystyn</LastName>
<ForeName>Henry</ForeName>
<Initials>H</Initials>
<AffiliationInfo><Affiliation>Inhalation Consultancy Ltd, Yeadon, Leeds, West Yorkshire, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Price</LastName>
<ForeName>David B</ForeName>
<Initials>DB</Initials>
<AffiliationInfo><Affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK. dprice@rirl.org.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK. dprice@rirl.org.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Molimard</LastName>
<ForeName>Mathieu</ForeName>
<Initials>M</Initials>
<AffiliationInfo><Affiliation>Department of Medical Pharmacology, CHU et Univ. de Bordeaux, Bordeaux, France.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Haughney</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Academic Primary Care, Division of Applied Health Sciences, University of Aberdeen, Polwarth Building, Foresterhill, Aberdeen, AB25 2ZD, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Bosnic-Anticevich</LastName>
<ForeName>Sinthia</ForeName>
<Initials>S</Initials>
<AffiliationInfo><Affiliation>Woolcock Institute of Medical Research, Sydney Medical School, University of Sydney and Sydney Local Health District, Sydney, Australia.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Lavorini</LastName>
<ForeName>Federico</ForeName>
<Initials>F</Initials>
<AffiliationInfo><Affiliation>Department of Experimental and Clinical Medicine, Careggi University Hospital, Florence, Italy.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Efthimiou</LastName>
<ForeName>John</ForeName>
<Initials>J</Initials>
<AffiliationInfo><Affiliation>Horizon Respiratory Consultancy, Oxford, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Shan</LastName>
<ForeName>Dawn</ForeName>
<Initials>D</Initials>
<AffiliationInfo><Affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Sims</LastName>
<ForeName>Erika</ForeName>
<Initials>E</Initials>
<AffiliationInfo><Affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</Affiliation>
</AffiliationInfo>
<AffiliationInfo><Affiliation>Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Burden</LastName>
<ForeName>Anne</ForeName>
<Initials>A</Initials>
<AffiliationInfo><Affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Hutton</LastName>
<ForeName>Catherine</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Research in Real-Life, 5a Coles Lane, Oakington, Cambridge, UK.</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Roche</LastName>
<ForeName>Nicolas</ForeName>
<Initials>N</Initials>
<AffiliationInfo><Affiliation>University Paris Descartes (EA2511), Respiratory and Intensive Care Medicine Department, Cochin Hospital Group, AP-HP, Paris, France.</Affiliation>
</AffiliationInfo>
</Author>
</AuthorList>
<Language>eng</Language>
<DataBankList CompleteYN="Y"><DataBank><DataBankName>ClinicalTrials.gov</DataBankName>
<AccessionNumberList><AccessionNumber>NCT01794390</AccessionNumber>
</AccessionNumberList>
</DataBank>
</DataBankList>
<PublicationTypeList><PublicationType UI="D003160">Comparative Study</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D016449">Randomized Controlled Trial</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2016</Year>
<Month>01</Month>
<Day>14</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>England</Country>
<MedlineTA>BMC Pulm Med</MedlineTA>
<NlmUniqueID>100968563</NlmUniqueID>
<ISSNLinking>1471-2466</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000305">Adrenal Cortex Hormones</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000318">Adrenergic beta-Agonists</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<CommentsCorrectionsList><CommentsCorrections RefType="Cites"><RefSource>J Asthma. 2010 Apr;47(3):251-6</RefSource>
<PMID Version="1">20394511</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Rev Med Pharmacol Sci. 2011 May;15(5):563-70</RefSource>
<PMID Version="1">21744753</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>BMC Pulm Med. 2006;6 Suppl 1:S6</RefSource>
<PMID Version="1">17140424</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Aerosol Med Pulm Drug Deliv. 2010 Oct;23(5):323-8</RefSource>
<PMID Version="1">20804428</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Curr Med Res Opin. 2007 Sep;23 Suppl 3:S13-20</RefSource>
<PMID Version="1">17925064</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Patient Educ Couns. 1997 Dec;32(1 Suppl):S87-95</RefSource>
<PMID Version="1">9516764</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Chest. 2007 Jun;131(6):1776-82</RefSource>
<PMID Version="1">17400675</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2011 Oct;105(10):1457-66</RefSource>
<PMID Version="1">21612903</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 1994 Jan;7(1):69-73</RefSource>
<PMID Version="1">8143834</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2010 Sep;104(9):1237-45</RefSource>
<PMID Version="1">20472415</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Care. 2006 Feb;51(2):158-72</RefSource>
<PMID Version="1">16441960</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Int J Chron Obstruct Pulmon Dis. 2014;9:889-904</RefSource>
<PMID Version="1">25210450</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>NPJ Prim Care Respir Med. 2014;24:14034</RefSource>
<PMID Version="1">25188403</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Aerosol Med Pulm Drug Deliv. 2008 Dec;21(4):321-8</RefSource>
<PMID Version="1">18823257</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Lung. 2003;181(4):183-92</RefSource>
<PMID Version="1">14692558</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 2011 Jun;37(6):1308-31</RefSource>
<PMID Version="1">21310878</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Allergy Asthma Clin Immunol. 2013 Mar 06;9(1):8</RefSource>
<PMID Version="1">23510684</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Asthma. 2008 Mar;45(2):109-13</RefSource>
<PMID Version="1">18350401</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2008 Dec;102(12):1681-93</RefSource>
<PMID Version="1">18815019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 1998 Feb;11(2):350-4</RefSource>
<PMID Version="1">9551737</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Clin Pharm Ther. 1989 Apr;14(2):135-44</RefSource>
<PMID Version="1">2470768</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Prim Care Respir J. 2009 Dec;18(4):243-9</RefSource>
<PMID Version="1">19513494</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2006 Sep;100(9):1479-94</RefSource>
<PMID Version="1">16495040</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Ann Pharmacother. 2010 Feb;44(2):257-66</RefSource>
<PMID Version="1">20103611</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Care. 2014 Feb;59(2):223-30</RefSource>
<PMID Version="1">23882109</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Arzneimittelforschung. 2003;53(8):562-7</RefSource>
<PMID Version="1">13677246</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2011 Dec;105(12):1815-22</RefSource>
<PMID Version="1">21802271</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 2011 May;37(5):982-5</RefSource>
<PMID Version="1">21532013</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2011 Jun;105(6):930-8</RefSource>
<PMID Version="1">21367593</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Fam Pract. 1996 Feb;13(1):35-40</RefSource>
<PMID Version="1">8671102</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2013 Jan;107(1):37-46</RefSource>
<PMID Version="1">23098685</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2013 Dec;107(12):1817-21</RefSource>
<PMID Version="1">24120398</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Eur Respir J. 2002 Feb;19(2):246-51</RefSource>
<PMID Version="1">11866004</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Aerosol Med Pulm Drug Deliv. 2015 Feb;28(1):35-42</RefSource>
<PMID Version="1">24815999</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>J Aerosol Med. 2003 Fall;16(3):249-54</RefSource>
<PMID Version="1">14572322</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2015 Apr;109(4):451-8</RefSource>
<PMID Version="1">25771037</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Patient Educ Couns. 2008 Jul;72(1):26-33</RefSource>
<PMID Version="1">18314294</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2008 Apr;102(4):593-604</RefSource>
<PMID Version="1">18083019</PMID>
</CommentsCorrections>
<CommentsCorrections RefType="Cites"><RefSource>Respir Med. 2008 Jan;102(1):10-9</RefSource>
<PMID Version="1">17923402</PMID>
</CommentsCorrections>
</CommentsCorrectionsList>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000280" MajorTopicYN="N">Administration, Inhalation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000305" MajorTopicYN="N">Adrenal Cortex Hormones</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000318" MajorTopicYN="N">Adrenergic beta-Agonists</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D001249" MajorTopicYN="N">Asthma</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D018592" MajorTopicYN="N">Cross-Over Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D058995" MajorTopicYN="Y">Dry Powder Inhalers</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004867" MajorTopicYN="Y">Equipment Design</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
</MeshHeading>
</MeshHeadingList>
<OtherID Source="NLM">PMC4712500</OtherID>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2015</Year>
<Month>05</Month>
<Day>13</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2016</Year>
<Month>01</Month>
<Day>05</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2016</Year>
<Month>1</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2016</Year>
<Month>1</Month>
<Day>16</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2016</Year>
<Month>10</Month>
<Day>7</Day>
<Hour>6</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>epublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">26769482</ArticleId>
<ArticleId IdType="doi">10.1186/s12890-016-0169-5</ArticleId>
<ArticleId IdType="pii">10.1186/s12890-016-0169-5</ArticleId>
<ArticleId IdType="pmc">PMC4712500</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002330 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002330 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:26769482 |texte= Comparison of serious inhaler technique errors made by device-naïve patients using three different dry powder inhalers: a randomised, crossover, open-label study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:26769482" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
![]() | This area was generated with Dilib version V0.6.33. | ![]() |